Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Cell Therapy
50 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Manufacturing Partnership
Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program
PR-M03-24-01
Cell Therapy Manufacturing
Rethinking Cell Engineering for Cell Therapy Manufacturing
PAO-11-23-CL-03
Digitalization, AI, and Automation
Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds
PR-M10-23-05
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
PAO-09-23-CL-09
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
PAO-08-23-CL-04
Cord Blood Bank Alliance
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
PR-M07-23-01
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
PAO-03-23-CL-06
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
PR-M02-23-03
Cell Therapy
Moving from Autologous to Allogeneic Cell Therapies: Drivers and Hurdles
PAO-01-23-NI-01
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
PAO-12-022-CL-04
Cell Therapy
Bedside Cell Therapies: Point-of-Care Manufacturing Is Slowly Becoming a Reality
PAO-11-022-NI-08
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
PR-M11-22-06
iPSCs
Resolution Therapeutics and CCRM Sign Collaboration Agreement to Develop and Scale Up Manufacturing for Induced Pluripotent Stem Cell (iPSC)-Derived Macrophage Cell Therapies
PR-M11-22-04
Cell Therapy
Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
PAO-11-022-CL-01
Cell Therapy Manufacturing
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies
PR-M08-22-03
Cord Blood
Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use
PR-M08-22-02
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
PAO-07-022-CL-03
Contamination Control
Contamination Control Strategies for the Manufacture of Conventional and Next-Generation Biologics
PAO-07-022-CL-07
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
PAO-06-022--NI-06
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
PAO-06-022--NI-04
Cell Therapy
Fighting Solid Tumors by Targeting Neoantigens in a Personalized Manner
PAO-06-022-CL-03
Cell Therapy
A PODular Therapies-as-a-Service Approach To Fundamentally Change the CAR-T Cell Therapy Landscape
PAO-05-022-CL-05
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
PAO-05-22-R250-09
Regenerative Medicine
Eliminating Immunosuppression in Regenerative Medicine
PAO-04-22-R250-74
1
3
»